RxDoctor Payments Data

William Probasco

Foot and Ankle Surgery · Fairfield, CTNPI 1336503382

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (38.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. Arthrex accounts for 68.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $13,857 and has fallen 70.9% since, to $4,038 in 2025. Among foot and ankle surgery clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,720in general payments, 2019–2025

Across 92 payments — averaging $279.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$18K
  • Polaris Technology Solutions LLC$4K
  • Paragon 28, Inc.$2K
  • Zimmer Biomet$708
  • Stryker$616
  • Supreme Orthopedic Systems, LLC$503
  • plus $846 from 9 others

What the payments were for

  • Grants$10,00039%
  • Travel & lodging$6,93027%
  • Food & beverage$3,46313%
  • Education$5,32721%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,720 in reported general payments places this provider in the 90th percentile of 89 foot and ankle surgery providers in Connecticut.

See all foot and ankle surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$127,463
Medicare patients
250
Services billed
993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib22$327
Ondansetron OdtOndansetron14$135
Oxycodone Hcl17$85

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Fairfield

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →